Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Energy Select Sector SPDR Fund — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Energy Select Sector SPDR Fund trades at $65.13 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is far larger — about 3.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Energy Select Sector SPDR Fund is more actively traded (50,409,268 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| HALO | XLE | |
|---|---|---|
Market Cap | $12.58B | $40.84B |
Volume | 2,179,278 | 50,409,268 |
Sector | Health | — |
52-Week High | $115.22 | $65.93 |
52-Week Low | $61.63 | $42.61 |
Typical Hold Time | 1 Days | 67 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLE trades at $65.09, up 2.7% today amid bullish technical signals from moving averages, though oscillators show caution with RSI levels in overbought territory. The energy ETF faces mixed sentiment as oil prices surge above $100 due to Middle East tensions while futures traders bet on a potential 12% sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures affecting energy markets.
Outlook remains volatile with geopolitical risks driving short-term gains but fundamental headwinds from potential oil price corrections. Key risks include oil market volatility and Federal Reserve policy impacts, while technical support at $64-$65 provides near-term stability. Investors should weigh high current energy prices against recessionary pressures that could dampen demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
